Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kim M Smits

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
Clinical Epigenetics|April 16, 2021
Identification of DNA methylation markers for early detection of CRC indicates a role for nervous system-related genes in CRCGlenn Rademakers, Maartje Massen, Alexander Koch, et al.
Nature Reviews. Clinical Oncology|May 2, 2018
Author Correction: Analysis of DNA methylation in cancer: location revisitedAlexander Koch, Sophie C Joosten, Zheng Feng, et al.
Nature Reviews. Clinical Oncology|April 19, 2018
Analysis of DNA methylation in cancer: location revisitedAlexander Koch, Sophie C Joosten, Zheng Feng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2014
CHFR promoter methylation indicates poor prognosis in stage II microsatellite stable colorectal cancerArjen H G Cleven, Sarah Derks, Muriel X G Draht, et al.
Molecular Carcinogenesis|September 30, 2022
Energy balance-related factors in childhood and adolescence and risk of colorectal cancer based on KRAS, PIK3CA, and BRAF mutations and MMR statusJosien C A Jenniskens, Kelly Offermans, Colinda C J M Simons, et al.
Journal of Cancer Research and Clinical Oncology|May 13, 2022
Energy balance-related factors and risk of colorectal cancer based on KRAS, PIK3CA, and BRAF mutations and MMR statusJosien C A Jenniskens, Kelly Offermans, Colinda C J M Simons, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 25, 2010
Loss of SerpinA5 protein expression is associated with advanced-stage serous ovarian tumorsIngrid T G W Bijsmans, Kim M Smits, Pauline de Graeff, et al.
Cancer Medicine|July 5, 2022
Association between mutational subgroups, Warburg-subtypes, and survival in patients with colorectal cancerKelly Offermans, Josien C A Jenniskens, Colinda C J M Simons, et al.
The American Journal of Pathology|January 1, 2010
Prognostic significance of Gremlin1 (GREM1) promoter CpG island hypermethylation in clear cell renal cell carcinomaIris J H van Vlodrop, Marcella M L Baldewijns, Kim M Smits, et al.
Carcinogenesis|May 3, 2003
K-ras oncogene mutations in sporadic colorectal cancer in The Netherlands Cohort StudyMirian Brink, Anton F P M de Goeij, Matty P Weijenberg, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Clinical Epigenetics|April 16, 2021
Identification of DNA methylation markers for early detection of CRC indicates a role for nervous system-related genes in CRCGlenn Rademakers, Maartje Massen, Alexander Koch, et al.
Nature Reviews. Clinical Oncology|May 2, 2018
Author Correction: Analysis of DNA methylation in cancer: location revisitedAlexander Koch, Sophie C Joosten, Zheng Feng, et al.
Nature Reviews. Clinical Oncology|April 19, 2018
Analysis of DNA methylation in cancer: location revisitedAlexander Koch, Sophie C Joosten, Zheng Feng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2014
CHFR promoter methylation indicates poor prognosis in stage II microsatellite stable colorectal cancerArjen H G Cleven, Sarah Derks, Muriel X G Draht, et al.
Molecular Carcinogenesis|September 30, 2022
Energy balance-related factors in childhood and adolescence and risk of colorectal cancer based on KRAS, PIK3CA, and BRAF mutations and MMR statusJosien C A Jenniskens, Kelly Offermans, Colinda C J M Simons, et al.
Journal of Cancer Research and Clinical Oncology|May 13, 2022
Energy balance-related factors and risk of colorectal cancer based on KRAS, PIK3CA, and BRAF mutations and MMR statusJosien C A Jenniskens, Kelly Offermans, Colinda C J M Simons, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 25, 2010
Loss of SerpinA5 protein expression is associated with advanced-stage serous ovarian tumorsIngrid T G W Bijsmans, Kim M Smits, Pauline de Graeff, et al.
Cancer Medicine|July 5, 2022
Association between mutational subgroups, Warburg-subtypes, and survival in patients with colorectal cancerKelly Offermans, Josien C A Jenniskens, Colinda C J M Simons, et al.
The American Journal of Pathology|January 1, 2010
Prognostic significance of Gremlin1 (GREM1) promoter CpG island hypermethylation in clear cell renal cell carcinomaIris J H van Vlodrop, Marcella M L Baldewijns, Kim M Smits, et al.
Carcinogenesis|May 3, 2003
K-ras oncogene mutations in sporadic colorectal cancer in The Netherlands Cohort StudyMirian Brink, Anton F P M de Goeij, Matty P Weijenberg, et al.
Pageof 7